Works matching AU Zhang, Yu‐jing

Results: 85
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 9, p. 1047, doi. 10.1002/ajh.25878
    By:
    • Qi, Shu‐Nan;
    • Yang, Yong;
    • Zhang, Yu‐Jing;
    • Huang, Hui‐Qiang;
    • Wang, Ying;
    • He, Xia;
    • Zhang, Li‐Ling;
    • Wu, Gang;
    • Qu, Bao‐Lin;
    • Qian, Li‐Ting;
    • Hou, Xiao‐Rong;
    • Zhang, Fu‐Quan;
    • Qiao, Xue‐Ying;
    • Wang, Hua;
    • Li, Gao‐Feng;
    • Zhu, Yuan;
    • Cao, Jian‐Zhong;
    • Wu, Jun‐Xin;
    • Wu, Tao;
    • Zhu, Su‐Yu
    Publication type:
    Article
    11
    12
    13
    14

    Risk‐dependent curability of radiotherapy for elderly patients with early‐stage extranodal nasal‐type NK/T‐cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).

    Published in:
    Cancer Medicine, 2018, v. 7, n. 12, p. 5952, doi. 10.1002/cam4.1849
    By:
    • Chen, Bo;
    • Zhu, Su‐Yu;
    • Shi, Mei;
    • Su, Hang;
    • Wang, Ying;
    • He, Xia;
    • Xu, Li‐Ming;
    • Yuan, Zhi‐Yong;
    • Zhang, Li‐Ling;
    • Wu, Gang;
    • Qu, Bao‐Lin;
    • Qian, Li‐Ting;
    • Hou, Xiao‐Rong;
    • Zhang, Fu‐Quan;
    • Zhang, Yu‐Jing;
    • Zhu, Yuan;
    • Cao, Jian‐Zhong;
    • Lan, Sheng‐Min;
    • Wu, Jun‐Xin;
    • Wu, Tao
    Publication type:
    Article
    15
    16
    17
    18
    19

    On P-sober Spaces.

    Published in:
    Acta Mathematica Sinica, 2023, v. 39, n. 9, p. 1768, doi. 10.1007/s10114-023-2197-4
    By:
    • Zhang, Yu Jing;
    • Zhao, Bin
    Publication type:
    Article
    20
    21
    22
    23
    24

    Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2669, doi. 10.1080/10428194.2019.1602265
    By:
    • Qi, Shu-Nan;
    • Xu, Li-Ming;
    • Yuan, Zhi-Yong;
    • Wu, Tao;
    • Zhu, Su-Yu;
    • Shi, Mei;
    • Su, Hang;
    • Wang, Ying;
    • He, Xia;
    • Zhang, Li-Ling;
    • Wu, Gang;
    • Qu, Bao-Lin;
    • Qian, Li-Ting;
    • Hou, Xiao-Rong;
    • Zhang, Fu-Quan;
    • Zhang, Yu-Jing;
    • Zhu, Yuan;
    • Cao, Jian-Zhong;
    • Lan, Sheng-Min;
    • Wu, Jun-Xin
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Aflatoxin B.

    Published in:
    International Journal of Cancer, 2006, v. 119, n. 5, p. 985, doi. 10.1002/ijc.21699
    By:
    • Zhang, Yu-Jing;
    • Rossner, Pavel;
    • Chen, Yu;
    • Agrawal, Meenakshi;
    • Wang, Qiao;
    • Wang, Lillian;
    • Ahsan, Habibul;
    • Yu, Ming-Whei;
    • Lee, Po-Huang;
    • Santella, Regina M.
    Publication type:
    Article
    39

    Inactivation of the DNA repair gene O.

    Published in:
    International Journal of Cancer, 2003, v. 103, n. 4, p. 440, doi. 10.1002/ijc.10852
    By:
    • Zhang, Yu-Jing;
    • Chen, Yu;
    • Ahsan, Habibul;
    • Lunn, Ruth M.;
    • Lee, Po-Huang;
    • Chen, Chien-Jen;
    • Santella, Regina M.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50